Climate change is one of the biggest challenges to the resilience of health systems and is becoming widely recognized as the greatest threat to human health. Sanofi cares for the planet and human health by strengthening its resilience to environmental changes, including mitigating its dependencies on natural resources and minimizing the environmental impact of its products and activities, aligned to its Planet Care roadmap.
Sanofi’s strategy embraces a holistic approach to climate issues, moving towards net zero greenhouse gas (GHG) emissions by 2045 with an intermediate trajectory towards carbon neutrality by 2030 (all scopes) by integrating environmental stewardship into every facet of its operations, under the conditions indicated below.
Our Ambition
Validation of our objectives by the Science Based Target initiative (SBTi) confirms the scientific basis of our objectives, as part of the planet-wide efforts needed to limit global warming. Our validated science-based targets are:
- reducing our scope 1 and 2 greenhouse gas emissions by 55% in absolute terms by 2030, versus a 2019 baseline (near-term target);
- reducing our scope 3 emissions by 30% in absolute terms by 2030, versus a 2019 baseline (near-term target); and
- reducing our scope 1, 2 and 3 emissions by 90% between 2019 and 2045 as part of Net Zero target.
Additional supporting goals include:
- Increasing our annual supply of renewably sourced electricity from 11% in 2019 to 80% in 2025 and 100% in 2030 as part of RE100 initiative;
- Moving to 80% of sales fleet meeting Sanofi’s Ecofleet requirements by 2030;
- Investing in carbon offset projects that combine a positive impact on both communities and the environment to offset residual emissions from 2030, on top of a science-based emission reduction trajectory.
Our 2024 Performance
- A 47% decrease in scopes 1 and 2 GHG emissions (vs the 2019 baseline).
- A 10% reduction in scope 3 GHG emissions (vs the 2019 baseline).
- 85% renewable electricity sourcing (vs 16% in 2019).
- Sanofi’s efforts to fight climate change are evaluated annually by CDP and achieved an A- ‘Leadership’ ranking.
- 50% of Sanofi’s fleet meets the eco-fleet criteria.
Action on Climate Change - Reducing Scope 1 & 2 GHG Emissions
- Energy reduction and efficiency: Energy saving programs are in place at all relevant sites.
- Sanofi's Energy efficiency program is driven by a global management system that covers all relevant operations; it includes a reference framework, an internal audit and performance review program.
- The Energy management system is assessed and certified as meeting the requirements of ISO 50001:2018 for the following activities: research, development, manufacturing, distribution centres and related support functions. This certification covers more than 80% of Sanofi’s energy consumption.
- The Energy programme aims to reduce energy consumption by 15% in existing facilities by 2025 compared to 2021.
- Energy decarbonization:
- Sanofi is a member of the RE100 initiative and is committed to delivering 100% renewable electricity by 2030 with the:
-
- Sourcing of RE100 compliant renewable electricity at all relevant sites
- Installation of solar panels; Sanofi can self generates up to 25 GWh per year.
- Transition to renewable thermal energy to meet heating needs by increasing the use of biomethane and biomass. A long-term biomethane supply contract (2024-2030) has been signed in France for 210 GWh per year.
-
- Refrigerant gas control, including replacing existing refrigerant gases with lower global warming potential alternatives and improving leak detection and prevention.
- Reducing the climate impact of our sales fleet through vehicle efficiency standards and transitioning to an eco-fleet (moving to 80%) by 2030 targeting lower emission alternatives (hybrid, electric and biofuel vehicles).
Action on Climate Change - Reducing Scope 3 GHG Emissions
- Decarbonization of inputs and raw materials: Sanofi is seeking to replace the most carbon-intensive raw materials with more environmentally sustainable alternatives or by identifying less carbon-intensive suppliers. Furthermore, our eco-design program makes it possible to identify levers for the decarbonization of activities and products. Eco-design is a systemic approach that aims to integrate environmental criteria from the design stage of a product, but also into its continuous improvement processes.
- Supplier engagement: We are engaging with suppliers to support their work towards improving their environmental footprint and fighting climate change. In 2024, there were 205 suppliers engaged in the Supplier Engagement Program, covering 75% of supplier-related emissions and representing 50% of our procurement spend. Moreover, through the Energize Program, a collaborative effort within the pharmaceutical industry, we help our shared supply chains convert to renewable energy.
- Additionally, Sanofi is implementing comprehensive measures to reduce value chain emissions across multiple areas such as optimizing distribution networks, shifting from air to sea freight for product transport, reducing business air travel and reducing operational waste.
Action on Climate Change - Offsetting
Understanding that not all emissions can be immediately abated, we will also invest in community-focused carbon offsetting projects to compensate our residual emissions from 2030. Our projects do notjust mitigate remaining emissions, they do so through the lens of community engagement and environmental restoration.
Five long-term carbon offset projects (up to 21 years) have been launched since 2022, and more are under consideration. The selection of compensation mechanisms will focus on effective projects that associate a positive social impact on communities and on the environment, with “best in class” international certification standards recognized by financial regulators.